Literature DB >> 29735615

Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina.

Prasana Khatiwoda1, Rae Jean Proeschold-Bell2, Christina S Meade3, Lawrence P Park3, Scott Proescholdbell4.   

Abstract

BACKGROUND Naloxone-an opioid antagonist that reverses the effects of opioids-is increasingly being distributed in non-medical settings. We sought to identify the facilitators of, and barriers to, opioid users using naloxone kits in North Carolina.METHODS In 2015, we administered a 15-item survey to a convenience sample of 100 treatment seekers at 4 methadone/buprenorphine Medication Assisted Therapy (MAT) clinics in North Carolina.RESULTS Seventy-four percent of participants reported having ever gotten a naloxone kit; this percentage was higher for females (81%) than males (63%) (P = .06). The primary reason given for not having a kit was not knowing where to get one. Only 6% had heard of kits from the media and only 5% received one from a medical provider. Among kit recipients, 56% of both females and males reported mostly or sometimes carrying the kit, with additional participants reporting always. Reasons for not carrying a kit were no longer being around drugs, forgetting it, and the kit being too large. Men discussed the difficulties of carrying the naloxone kits, which are currently too large to fit in a pocket. Ninety-four percent of naloxone users reported intending to call emergency services in case of an overdose emergency.LIMITATIONS Study limitations included a small sample, participants limited to MAT clinics, and a predominantly white sample.CONCLUSIONS MAT treatment seekers reported a willingness to carry and use naloxone kits. Education, outreach, media, and medical providers need to promote naloxone kits. A smaller kit may increase the likelihood of men carrying one. ©2018 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29735615     DOI: 10.18043/ncm.79.3.149

Source DB:  PubMed          Journal:  N C Med J        ISSN: 0029-2559


  10 in total

1.  Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.

Authors:  Elizabeth Donovan; Patricia Case; Jeffrey P Bratberg; Janette Baird; Dina Burstein; Alexander Y Walley; Traci C Green
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

2.  Businesses in high drug use areas as potential sources of naloxone during overdose emergencies.

Authors:  Kristin E Schneider; Saba Rouhani; Noelle P Weicker; Miles Morris; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2022-02-17       Impact factor: 4.492

3.  A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.

Authors:  Hawraa Sameer Sajwani; Anna V Williams
Journal:  Harm Reduct J       Date:  2022-10-20

4.  Sex Differences in Substance Use and Misuse: A Toxicology Investigators' Consortium (ToxIC) Registry Analysis.

Authors:  Gillian A Beauchamp; Jennifer L Carey; Mikayla B Hurwitz; Briana N Tully; Matthew D Cook; Robert D Cannon; Kenneth D Katz; Andrew L Koons; Hope Kincaid; Marna Rayl Greenberg
Journal:  Subst Abuse Rehabil       Date:  2020-09-29

5.  More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD.

Authors:  Lauren Dayton; Rachel E Gicquelais; Karin Tobin; Melissa Davey-Rothwell; Oluwaseun Falade-Nwulia; Xiangrong Kong; Michael Fingerhood; Abenaa A Jones; Carl Latkin
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.752

6.  Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden.

Authors:  Katja Troberg; Pernilla Isendahl; Marianne Alanko Blomé; Disa Dahlman; Anders Håkansson
Journal:  Front Public Health       Date:  2022-03-10

7.  Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration.

Authors:  Margaret Lowenstein; Hareena K Sangha; Anthony Spadaro; Jeanmarie Perrone; M Kit Delgado; Anish K Agarwal
Journal:  Harm Reduct J       Date:  2022-08-26

8.  Trends in overdose experiences and prevention behaviors among people who use opioids in Baltimore, MD, 2017-2019.

Authors:  Lauren Dayton; Alyona Mazhnaya; Kristin E Schneider; Xiangrong Kong; Abigail Winiker; Melissa Davey-Rothwell; Karin E Tobin; Carl A Latkin
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

9.  State-led opioid overdose prevention efforts: Challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS).

Authors:  Natasha Underwood; Cherie Rooks-Peck; Nida Ali; April Wisdom; Olga Costa; Amber Robinson; Jamie Mells; Sarah Bacon
Journal:  Subst Abus       Date:  2021-04-02       Impact factor: 3.716

10.  Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?

Authors:  Vivian Y O Au; Tea Rosic; Nitika Sanger; Alannah Hillmer; Caroul Chawar; Andrew Worster; David C Marsh; Lehana Thabane; Zainab Samaan
Journal:  Harm Reduct J       Date:  2021-07-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.